Isothermal amplification-assisted diagnostics for COVID-19

被引:55
|
作者
De Felice, Mariarita [1 ]
De Falco, Mariarosaria [1 ]
Zappi, Daniele [2 ]
Antonacci, Amina [2 ]
Scognamiglio, Viviana [2 ]
机构
[1] CNR, Inst Biosci & BioResources, Dept Biol Agr & Food Sci, Via P Castellino 111, I-80100 Naples, Italy
[2] CNR, Inst Crystallog, Dept Chem Sci & Mat Technol, Via Salaria Km 29-300, I-00015 Rome, Italy
来源
关键词
Isothermal amplification; SARS-CoV-2; diagnostics; Sensitive and specific screening; High throughput; Biosensors; RAPID DETECTION; GENE; NUCLEOTIDE; PCR; RNA;
D O I
10.1016/j.bios.2022.114101
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The scenery of molecular diagnostics for infectious diseases is rapidly evolving to respond to the COVID-19 epidemic. The sensitivity and specificity of diagnostics, along with speed and accuracy, are crucial requirements for effective analytical tools to address the disease spreading around the world. Emerging diagnostic devices combine the latest trends in isothermal amplification methods for nucleic acids with state-of-the-art biosensing systems, intending to bypass roadblocks encountered in the last 2 years of the pandemic. Isothermal nucleic acid amplification is a simple procedure that quickly and efficiently accumulates nucleic acid sequences at a constant temperature, without the need for sophisticated equipment. The integration of isothermal amplification into portable biosensing devices confers high sensitivity and improves screening at the point of need in low-resource settings. This review reports the latest trends reached in this field with the latest examples of isothermal amplification-powered biosensors for detecting SARS-CoV-2, with different configurations, as well as their intrinsic advantages and disadvantages.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Point of Care Diagnostics in the Age of COVID-19
    Rezaei, Meysam
    Razavi Bazaz, Sajad
    Zhand, Sareh
    Sayyadi, Nima
    Jin, Dayong
    Stewart, Martin P.
    Ebrahimi Warkiani, Majid
    DIAGNOSTICS, 2021, 11 (01)
  • [42] The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics
    Naidoo, Dhaneshree Bestinee
    Chuturgoon, Anil Amichund
    MOLECULAR DIAGNOSIS & THERAPY, 2023, 27 (02) : 193 - 226
  • [43] COVID-19 rapid diagnostics: practice review
    Reynard, Charles
    Allen, Joy A.
    Shinkins, Bethany
    Prestwich, Graham
    Goves, Johnathan
    Davies, Kerrie
    Body, Richard
    EMERGENCY MEDICINE JOURNAL, 2022, 39 (01) : 70 - 76
  • [44] COVID-19 diagnostics: Molecular biology to nanomaterials
    Perveen, Summaya
    Negi, Anjali
    Gopalakrishnan, Varun
    Panda, Satyajit
    Sharma, Vinay
    Sharma, Rashmi
    CLINICA CHIMICA ACTA, 2023, 538 : 139 - 156
  • [45] Academic labs supporting COVID-19 diagnostics
    Veldhoen, Marc
    Zuzarte-Luis, Vanessa
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 (01) : 13 - 16
  • [46] COVID-19: Discovery, diagnostics and drug development
    Asselah, Tarik
    Durantel, David
    Pasmant, Eric
    Lau, George
    Schinazi, Raymond F.
    JOURNAL OF HEPATOLOGY, 2021, 74 (01) : 168 - 184
  • [48] COVID-19 Clinical Diagnostics and Testing Technology
    Chau, Cindy H.
    Strope, Jonathan D.
    Figg, William D.
    PHARMACOTHERAPY, 2020, 40 (08): : 857 - 868
  • [49] The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics
    Dhaneshree Bestinee Naidoo
    Anil Amichund Chuturgoon
    Molecular Diagnosis & Therapy, 2023, 27 : 193 - 226
  • [50] TELEHEALTH DIAGNOSTICS DURING THE COVID-19 PANDEMIC
    Westrupp, N.
    Du Berry, C.
    Welsh, L.
    RESPIROLOGY, 2021, 26 : 9 - 9